Skeletal F-PSMA-1007 uptake in prostate cancer patients
Background/objectives: Accurate and uniform interpretation and reporting of metastatic prostate cancer (PCa) lesions on prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) are indispensable. 18 F-PSMA-1007 is increasingly used because of its favorable...
Main Authors: | Jorinde Janssen, Walter Noordzij, Ton Velleman, Igle Jan de Jong, Johannes A. Langendijk, J. Fred Verzijlbergen, Gilles N. Stormezand, Shafak Aluwini |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-06-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359231179311 |
Similar Items
-
Application of 68Ga-PSMA-11 and 18F-PSMA-1007 in prostate cancer
by: Hu Siqi, Zhang Yong
Published: (2022-01-01) -
Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases
by: Jorinde Janssen, et al.
Published: (2023-07-01) -
Agreement between PSMA-RADS and E-PSMA systems in classifying [18F]PSMA-1007 PET/CT lesions among prostate cancer patients: exploring the correlation between lesion size and uptake
by: Miguel Mendoza-Ávila, et al.
Published: (2024-03-01) -
Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET/CT for prostate cancer
by: Yu Ching Lau, et al.
Published: (2022-09-01) -
Intra-Individual Comparison of Physiologic [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis
by: Emil Novruzov, et al.
Published: (2023-05-01)